Vivos Therapeutics, Inc. (VVOS) Income Annual - Discounting Cash Flows
VVOS
Vivos Therapeutics, Inc.
VVOS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing 2025-05-15 2025-03-31 2024-07-30 2023-03-30 2022-03-31 2021-03-25 2019-12-31 2018-12-31
Revenue 14.63 15.03 13.8 16.02 16.89 13.07 11.39 3.79
Cost of Revenue 6.04 6.01 5.53 6 4.28 2.65 2.74 1.08
Gross Profit 8.59 9.02 8.27 10.02 12.6 10.41 8.66 2.71
Operating Expenses 19.72 20.19 25.57 35.05 32.08 19.12 19.23 11.05
Research & Development 0.1 0 0.1 0.2 0 0 0 0
Selling, General and Administrative 19.28 19.61 24.85 34.38 31.34 18.4 18.48 10.44
Other Operating Expenses 0.335 0.581 0.621 0.469 0.733 0.718 0.751 0.611
Operating Income -11.13 -11.17 -17.3 -25.03 -19.47 -8.71 -10.58 -8.34
Net Non-Operating Interest 0 0 0 0.089 0.103 -0.017 -0.117 -0.103
Interest Income 0 0 0 0.089 0.117 0.08 0.021 0
Interest Expense 0 0 0 0 0.014 0.097 0.138 0.103
Equity & Other Income/(Expense) -0.109 0.035 3.71 1.1 -0.92 -3.33 -0.06 0
Income Before Tax -11.24 -11.14 -13.58 -23.84 -20.29 -12.06 -10.75 -8.44
Income Tax Expense -1.44 0 0 -1.19 0.005 -3.23 0.138 0.103
Income Attributable to Non-Controlling Interest 1.44 0 0 0 0 0 0 0
Net Income -11.24 -11.14 -13.58 -22.66 -20.29 -8.82 -10.89 -8.54
Depreciation and Amortization 0.612 0.581 0.621 0.669 0.733 0.718 0.751 0.611
EBITDA -10.52 -10.59 -16.68 -24.36 -18.74 -7.99 -9.83 -7.73
Earnings Per Share (EPS) -0.19 -1.68 -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
Diluted Earnings Per Share -0.19 -1.68 -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
Weighted Average Shares Outstanding 8.6 5.02 1.22 0.92 0.849 0.728 0.496 0.462
Diluted Weighted Average Shares Outstanding 8.6 5.02 1.22 0.92 0.849 0.728 0.496 0.462
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us